Drug intelligence / Profile preview

(S)-lacosamide

Development stage
Preclinical
Lead developer
UCB
Modality
Small Molecules
Administration
Oral
01

Overview

(S)-lacosamide is a small molecule drug that is an inactive analog of the clinically approved anti-epileptic drug (R)-Lacosamide (Vimpat®). Despite being an inactive analog of (R)-Lacosamide, (S)-lacosamide exhibits a distinct mechanism of action relevant to migraine treatment. It inhibits the phosphorylation of collapsin response mediator protein 2 (CRMP2) by cyclin dependent kinase 5 (Cdk5) in sensory neurons. This action leads to a decrease in depolarization-evoked Ca2+ influx and subsequently blocks the release of calcitonin gene related peptide (CGRP) from dural nerve terminals. (S)-lacosamide has shown potential as a therapy for acute migraine by inhibiting cutaneous allodynia in animal models.

Other names
(S)-LCM
02

Targets

CRMP2 (Collapsin response mediator protein 2)CDK5 (Cyclin-dependent kinase 5)CACNA1B (Voltage-dependent N-type calcium channel subunit alpha-1B)

Beyond the preview

Go deeper on (S)-lacosamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (S)-lacosamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call